within Pharmacolibrary.Drugs.ATC.J;

model J01DD13
  extends Pharmacokinetic.Models.PK_1C_enteral(
    weight         = 70,
    F              = 0.5,
    Cl             = 0.075,
    adminDuration  = 600,
    adminMass      = 0.2,
    adminCount     = 1,
    Vd             = 0.032,
    Cmin           = 0.001,
    Cmax           = 0.01,
    Ctox_peak      = 0.02,
    Ctox_trough    = 0.01,
    ka             = 0.018333333333333333,
    Tlag           = 10.200000000000001
  );

  annotation(Documentation(
    info ="<html><body><p>Cefpodoxime is an oral third-generation cephalosporin antibiotic used to treat a variety of bacterial infections, including respiratory tract, skin, urinary tract infections, and gonorrhea. It is approved for use in many countries and remains in clinical use.</p><h4>Pharmacokinetics</h4><p>Pharmacokinetic parameters in healthy adult volunteers after a single oral dose.</p><h4>References</h4><ol><li>Ayesha Farooq, Ammara Zamir, Imran Imran, Hamid Saeed, Faleh Alqahtani, Anees Ur Rehman, Waseem Ashraf, Muhammad Fawad Rasool,Clinical pharmacokinetics of cefpodoxime: a systematic review.,Expert opinion on drug metabolism & toxicology,2024<a href='https://pubmed.ncbi.nlm.nih.gov/39120118/'>https://pubmed.ncbi.nlm.nih.gov/39120118/</a></li><li>Gamal A E Mostafa, Yazeed H Al-Otaibi, Abdullah A Al-Badr,Cefpodoxime proxetil.,Profiles of drug substances, excipients, and related methodology,2019<a href='https://pubmed.ncbi.nlm.nih.gov/31029216/'>https://pubmed.ncbi.nlm.nih.gov/31029216/</a></li></ol></body></html>",
    revisions = "<html><body><ul><li>06/2025 model generated by LLM gpt-4.1, references by scholarly and scripts created by Tomas Kulhanek</li></ul></body></html>"
  ));
end J01DD13;
